How to manage the costs of adverse events in a CE analysis?
Have you already performed health economic analyses? Then you will definitely recognise the following. To what level is it relevant to include costs in the analysis? For quite a few parameters, it is clear that they can have a decisive influence on your analysis and in your decision-making process. However, sometimes the effort you have […]
Clinical data, the key to a good market access dossier
The chicken or the egg. It’s a question that keeps many busy. The budget can be synonymous with the chicken and innovations synonymous with the egg (or the other way around, of course …). Anyway, any kind of innovation results in shifts in resources (lower consumption, higher efficacy, fewer side effects). For pharmaceuticals, it is […]